DEPARTMENT OF OBSTETRICS & GYNAECOLOGY P.G. TEACHING SCHEDULE FOR DECEMBER, 2017
|
|
|
- Eleanor Matthews
- 5 years ago
- Views:
Transcription
1 DEPARTMENT OF OBSTETRICS & GYNAECOLOGY P.G. TEACHING SCHEDULE FOR DECEMBER, 2017 THEORY (MON,TUE, FRI, SAT)TIME: 4:30 PM-5:30 PM DATE TOPIC FACULTY 1/12/17 PRECOCIOUS PUBERTY DR.SARALA SREEDHAR 2/12/17 MANAGEMENT OF SHOCK DR.SOBHA.S.NAIR 4/12/17 INTRAUTERINE DEVICES DR.DEEPTHI SHARMA 5/12/17 PNDT ACT DR.JANU.M.K 8/12/17 MTP DR.RADHAMANY.K 9/12/17 PRENATAL TESTING DR.SUDHA.S 11/12/17 DEVELOPMENT OF FEMALE GENITAL TRACT 12/12/17 PRECONCEPTIONAL COUNSELLING AND CARE DR.CHITRA DR.SOBHA.S.NAIR 15/12/17 HAEMOGLOBINOPATHIES DR.DEEPTHI SAHRMA 16/12/17 CARDIAC DISEASE IN DR.SARALA SREEDHAR 18/12/17 OVARIAN CANCER DR.RADHAMANY 19/12/17 OPERATIVE VAGINAL DELIVERIES DR.SUDHA.S 22/12/17 POSTMENOPAUSAL HRT DR.JANU.M.K 23/12/17 MANAGEMENT OF DIABETES IN DR.SOBHA.S.NAIR 26/12/17 RETAINED PLACENTA DR.SUDHA.S
2 29/12/17 CAESAREAN SECTION DR.CHITRA 30/12/17 PELVIC FLOOR REPAIR DR.RADHAMANY K SEMINAR (TUES, SAT)(TIME.8:30 AM-9:30 AM) DATE TOPIC PRESENTER MODERATORS 12/12/17 CARDIO VASCULAR DISEASES COMPLICATING DR UJJWALA DR RADHAMANY, DR SUDHA, DR SHOBA, DR VINITHA, DR SHARANYA, DR RAJASHREE 16/12/17 CA CERVIX DR DHANYA DR SUDHA, DR DEEPTI, DR, CHITRA, DR JANU, DR RAJASHREE, DR CINI 19/12/17 PCOD DR ANJALI DR RADHAMANY, DR SUDHA, DR SHOBA, DR SAVITHA, DR VINITHA, DR SHARANYA 23/12/17 PRIMARY AMENORRHEA DR SINDHU DR DEEPTHI, DR JANU, DR RAJASHREE, DR CINI 26/12/17 ABRUPTIO PLACENTA DR. DHANYA DR SARALA, DR CHITRA, DR VINITHA, DR SHARANYA 30/12/17 IUGR DR VIDHU DR SARALA, DR CHITRA, DR JANU, DR VINITHA, DR SAVITHA
3 JOURNAL CLUB (MON)(TIME : 8:30 AM-9:30 AM) DATE TOPIC PRESENTER MODERATOR 4/12/2017 THE USE OF INTRAPARTUM ULTRASOUND TO DIAGNOSE MALPOSITIONS AND CEPHALIC MALPRESENTATIONS 11/12/2017 IMMEDIATE POSTPARTUM LEVONORGESTREL INTRAUTERINE DEVICE INSERTION & BREASTFEEDING OUTCOMES : A NON- INFERIORITY RCT 18/12/2017 TSH, ANTI-THYROID ANTIBODIES & OUTCOMES 25/12/2017 EFFECT OF INTRAPARTUM VANCOMYCIN ON VAGINAL GROUP B STREPTOCOCCUS COLONY COUNTS DR. SHYAMALA Dr. SARALA SREEDAR, DR. CHITHRA, DR. JANU, DR.SAVITHA, DR.ASHA DR. SINDHU DR. ISHA DR. AJITHA DR.RADHAMANY,DR.SUDHA, DR. DEEPTI, DR.SOBHA,DR.RAJASREE, DR.CINI DR.SARALA SREEDHAR, DR.DEEPTI, DR.SUDHA, DR.RAJASREE, DR.CINI,DR SAVITHA DR.RADHAMANY,DR.SUDHA, DR.JAYASHREE,DR. DEEPTI, DR.CHITRA DR.SARANYA, DR.CINI
4 CASE PRESENTATION (WED,THURS): 8.30 AM 9.30 AM DATE TOPIC PRESENTER MODERATOR 6/12/17 FIBROID UTERUS 7/12/17 AUB 13/12/17 BREECH PRESENTATION DR.ANJALI DR.DHANYA DR.SINDHU DR.RADHAMANY, DR.SUDHA,DR.SOBHA,DR.VINITH A,DR.JANU,DR SARANYA DR SUDHA,DR DEEPTI,DR CINI,DR CHITHRA,DRVINITHA,DR RAJASHREE DR RADHAMANY,DR SARALA,DR SHOBA,DR VINITHA,DR RAJASHREE,DR SARANYA 14/12/17 MULTIPLE DR.ANJALI DR.SARALA,DR DEEPTHI,DR SHOBA, DR. SAVITHA, DR. RAJASHREE, DR. CINI 20/12/17 PREECLAMPSIA 27/12/17 PREVIOUS CS 28/12/17 HEART DISEASE COMPLICATING DR.DHANYA DR.SRUTHI DR.SINDHU DR RADHAMANY,DR SHOBA,DR VINITA,DR CHITHRA,DR CINI,DR SARANYA DR.RADHAMANY,DR.SHOBA.,DR. RAJASREE,DR.CINI,DR SARANYA,DR VINITHA DR.SARALA,DR.SUDHA,DR.DEEP THI,DR.RAJASREE,DR.CINI,DR SAVITHA,DR VINITHA
5 GROUP DISCUSSION (FRIDAY) (TIME: 8:30 AM-9:30 AM.) DATE TOPIC FACULTY 1/12/17 CIN DR RADHAMANY, DR SARALA SREEDHAR, DR SUDHA DR DEEPTI DR CHITHRA DR JANU DR SOBHA DR VINITA 8/12/17 CA CERVIX DR.SARALA,DR.SUDHA, DR.DEEPTI,DR CHITHRA, DR JANU, DR RAJASHREE, DR SAVITHA, DR VINITA, 15/12/17 SCREENING,DIAGNOSIS AND MANAGEMENT OF CA OVARY 22/12/17 CA BREAST SCREENING, DIAGNOSIS AND TREATMENT IN 29/12/17 ENDOMETRIAL HYPERPLASIA DR RADHAMANY, DR SUDHA DR CHITHRA DR JANU DR SOBHA DR VINITHA DR SUDHA DR DEEPTI DR CHITHRA DR JANU DR SOBHA DR SAVITHA DR.RADHAMANY, DR.SARALA,DR CHITHRA,DR RAJASHREE, DR SARANYA, DR VINITA, DR CINI BEDSIDE TEACHING (TIME: MON,WED,FRI PM & SATURDAY AM) DATE TOPIC FACULTY 4/12/17 ABNORMAL LABOUR 6/12/17 PIH DR.SOBHA, DR.VINITA, DR.SUDHA,DR.DEEPTI, DRJANU DR.CINI, DR.RAJASHREE 8/12/17 FETAL SURVEILLANCE IN LABOUR DR.SOBHA, DR.VINITA, 9/12/17 ANAEMIA IN DR.SOBHA, DR.VINITA,
6 11/12/17 PLACENTA PREVIA 13/12/17 PREVIOUS CAESARIAN 15/12/17 RH NEGATIVE 16/12/17 PPH DR.SARALA, DR.CHITHRA, DR.JANU, DR.SAVITHA DR.SARALA, DR.CHITHRA, DR.JANU, DR.SAVITHA DR.SUDHA,DR.DEEPTI, DR JANU DR.CINI, DR.RAJASHREE DR RADHAMANY, DR JAYASHREE, DR SOBHA, DR VINEETHA 18/12/17 VENOUS THROMBOEMBOLISM IN DR.SOBHA, DR VINEETHA 20/12/17 ECTOPIC DR.SARALA, DR.CHITHRA, DR.JANU, DR.SAVITHA 22/12/17 23/12/17 FETAL GROWTH RESTRICTION CARDIAC DISEASES IN DR.RADHAMANY, DR JAYASHREE,DR SHOBHA, DR VINEETHA DR. SUDHA, DR. DEEPTHI, DR JANU, DR. RAJASHREE, DR CINI 26/12/17 GDM 29/12/17 BREECH PRESENTATION 30/12/17 PRETERM DELIVERY DR SARALA, DR CHITHRA, DR JANU, DR SAVITHA DR SUDHA. DR DEEPTHI,DR JANU, DR RAJASHREE, DR CINI DR RADHAMANY, DR JAYASHREE, DR SOBHA, DR VINEETHA
7 PROCEDURES YEARLY REPORT DECEMBER, 2017(MAJOR &MINOR) MAJOR MAJOR TOTAL MINOR OPEN LAP OPEN LAP MINOR TOTAL GRAND TOTAL DECEMBER, YEARLY CENSUS : DECEMBER, 2017 MONTH TOTAL LSCS NORMAL DELIVERY INSTRUMENTAL DELIVERY TOTAL DECEMBER, CLINICAL PROCEDURES: DECEMBER, 2017 CU-T Suture Papsmear MTP HPV Dressing insertion removal Vaginal swab+wound swab USG CTG Pessary Insertion TOTAL DECEMBER,
DEPARTMENT OF OBST. & GYNAECOLOGY PG TEACHING SCHEDULE
THEORY CLASSES Time: (4:30-5:30 PM) DEPARTMENT OF OBST. & GYNAECOLOGY PG TEACHING SCHEDULE DATE TOPIC FACULTY 3/3/17 Physiology Of Menstruation- Hormonal Imbalances Dr Chithra 4/3/17 Antihypertensive Drugs
RANZCOG Advanced Training Modules
RANZCOG Advanced Training Modules Generalist Obstetrics ATM and Generalist Gynaecology ATM The Generalist ATMs in each of Obstetrics and Gynaecology provide a framework for trainees to consolidate and
FRANZCOG Training Program Logbook Procedure List and Classification
FRANZCOG Training Program Logbook Procedure List and Classification This logbook procedure list provides sites and trainees with the major/minor classification of procedures in the online logbook. As detailed
WOMEN S HEALTH SERVICES
WOMEN S HEALTH SERVICES Committed to enhancing the total well-being of women throughout their lives Knowledge-Powered Medicine 877-WSU-DOCS upgdocs.org/womenshealth WOMEN S HEALTH SERVICES UPG Women s
CURRICULUM VITAE. (Revised 2018) Wendy S. Humphrey, M.D. F.A.C.O.G Adjunct Clinical Professor of Obstetrics and Gynecology
CURRICULUM VITAE (Revised 2018) Wendy S. Humphrey, M.D. F.A.C.O.G Adjunct Clinical Professor of Obstetrics and Gynecology 6553 Ridgewood Drive Naples, FL 34108 Telephone: (239) 514-8765 (Home) (239) 286-6932
POSTGRADUATE TRAINING AND ASSESSMENT IN OBSTETRICS AND GYNAECOLOGY LOG BOOK
POSTGRADUATE TRAINING AND ASSESSMENT IN OBSTETRICS AND GYNAECOLOGY LOG BOOK Approved by The UEMS Section of Obstetrics and Gynaecology and The European Board and College of Obstetrics and Gynaecology (EBCOG)
List of performance and attendance at practical training in Obstetrics, Gynaecology and Reproduction
List of performance and attendance at practical training in Obstetrics, Gynaecology and Reproduction Academic year: 0/ Name and surname: Explanation of proficiency levels of the required skills and/or
DR. S. J. KORE 2 DR.S.J.KORE INSTRUMENTAL VAGINAL DELIVERY-MOGS,MUMBAI 3 DR.S.J.KORE RECENT ADVANCES IN MANAGEMENT OF PPH-AMOGS,AURANGABAD
DR. S. J. KORE GUEST LECTURES: SR.NO NAME TOPIC & PLACE 1 DR.S.J.KORE E NOTES IN GYNAECOLOGY-AICOG,JAIPUR 2 DR.S.J.KORE INSTRUMENTAL VAGINAL DELIVERY-MOGS,MUMBAI 3 DR.S.J.KORE RECENT ADVANCES IN MANAGEMENT
ENTRY INTO SPECIALTY TRAINING USING THE CESR (CP) ROUTE DETAILS OF PREVIOUS POSTS IN OBSTETRICS & GYNAECOLOGY PRIOR TO APPOINTMENT TO NTN
ENTRY INTO SPECIALTY TRAINING USING THE CESR (CP) ROUTE DETAILS OF PREVIOUS POSTS IN OBSTETRICS & GYNAECOLOGY PRIOR TO APPOINTMENT TO NTN PERSONAL DETAILS Trainee name Surname Forename(s) NTN Details NTN
CPD questions for volume 17 number 1
DOI: 10.1111/tog.12170 The Obstetrician & Gynaecologist http://onlinetog.org 2015;17:62 7 questions for volume 17 number 1 credits can be claimed for the following questions online via the TOG submission
Name of the Department Obstetrics & Gynaecology
Name of the Department Obstetrics Gynaecology Name of Head of Department Dr. Prof. Veena Ganju Malla Date:22-11-2016 Location of the department in the Hospital - Maternity Nursing Home Faculty in the Department-
UKMEC SUMMARY TABLE HORMONAL AND INTRAUTERINE CONTRACEPTION
SUMMARY TABLE SUMMARY TABLE HORMONAL AND INTRAUTERINE CONTRACEPTION Cu-IUD = Copper-bearing intrauterine device; LNG-IUS = Levonorgestrel-releasing intrauterine system; IMP = Progestogen-only implant;
Study & Evaluation Scheme Of M.S. (Obstetrics & Gynaecology) [Applicable for the Batch till revised]
![Study & Evaluation Scheme Of M.S. (Obstetrics & Gynaecology) [Applicable for the Batch till revised]](/thumbs/84/89727513.jpg "Study & Evaluation Scheme Of M.S. (Obstetrics & Gynaecology) [Applicable for the Batch till revised]")
Study & Evaluation Scheme Of M.S. (Obstetrics & Gynaecology) [Applicable for the Batch 2015-16 till revised] TEERTHANKER MAHAVEER UNIVERSITY Delhi Road, Moradabad, Uttar Pradesh-244001 Website: www.tmu.ac.in
Postpartum LARC. (Long Acting Reversible Contraception) NURSING EDUCATION
Postpartum LARC (Long Acting Reversible Contraception) NURSING EDUCATION What is LARC Long-acting reversible contraception (LARC) methods include the intrauterine device (IUD) and the birth control implant.
Surgical Privileges Form: Obstetrics & Gynecology
Surgical Privileges Form: Obstetrics & Gynecology Applicant s Name:. License No. (If Any):... Clinical Privileges Request Scope of Practice:. Facility:.. Date:... Privileges Requested (To be completed
M-AFRAKHTEH. MD OCT.2017 SHOHADA HOSPITAL TAJRISH
Unrestricted M-AFRAKHTEH. MD OCT.2017 SHOHADA HOSPITAL TAJRISH Patients at imminent risk of exsanguination Manual aortic compression Resuscitative endovascular balloon occlusion of the aorta Uterine tourniquet
Ardhanu Kusumanto Oktober Contraception methods for gyne cancer survivors
Ardhanu Kusumanto Oktober 2017 Contraception methods for gyne cancer survivors Background cancer treatment Care of gyn cancer survivor Promotion of sexual, cardiovascular, bone, and brain health management
Symptomatology and Surgical Perspective of Scar Endometriosis: A Case Series of 16 Women
DOI 10.1007/s13224-016-0945-4 ORIGINAL ARTICLE Symptomatology and Surgical Perspective of Scar Endometriosis: A Case Series of 16 Women Sudha Sumathy 1 Janu Mangalakanthi 1 Kishore Purushothaman 2 Deepti
Primary Neonatal and paediatric Consultant Dr M Gnanabalan Operating Paediatric Surgeon Dr P Balamourugane Paediatric Pathologist Dr Seetha lakshmi
Dr C K Janaki Raman DNB Pediatrics Trainee Department of Pediatrics Mehta Childrens Hospital Primary Neonatal and paediatric Consultant Dr M Gnanabalan Operating Paediatric Surgeon Dr P Balamourugane Paediatric
BIOT221 Western Diagnostic Techniques
BIOT221 Western Diagnostic Techniques Session 10 Imaging Ultrasound Sonography Bioscience Department Endeavour College of Natural Health endeavour.edu.au 1 SESSION OBJECTIVES Under stand why imaging techniques
DEPARTMENT OF OBSTETRICS & PROFESSOR & HOD
DEPARTMENT OF OBSTETRICS & GYNECOLOGY OG DR. R NAGARATHNAMMA M.D. FELLOW OF IMSA PROFESSOR & HOD The department of Obstetrics and Gynecology in RRMCH established in the year 2004 has been providing comprehensive
Core Module 13: Gynaecological Problems
Core Module 13: Gynaecological Problems Learning outcomes: To understand and demonstrate appropriate knowledge, skills and attitudes in relation to common gynaecological disorders To understand paediatric
Abnormal uterine bleeding:
Primary Care Women s Health Forum 16th June 2010 Abnormal uterine bleeding: The University Of Birmingham T Justin Clark MD (Hons), MRCOG Consultant Obstetrician and Gynaecologist Birmingham Women s Hospital
Investigating HMB- an evidence based approach
BSGE Meeting: Contemporary management of heavy menstrual bleeding (HMB) in primary and secondary care: (7 th December 2018, RCOG) Investigating HMB- an evidence based approach T. Justin Clark MB ChB, MD(Hons),
Diabetes in Pregnancy
Diabetes in Pregnancy Ebony Boyce Carter, MD, MPH Division of Maternal Fetal Medicine Washington University School of Medicine Disclosures I have no financial disclosures to report. Objectives Review the
Cervical Cancer - Suspected
Cervical Cancer - Suspected Presentation for patients Asymptomatic presentation Symptomatic presentation History and examination Consider differential diagnoses RED FLAG! Cervix appears normal after examination
Instruction for the patient
WS 4 Case 3 STI and IUD Your situation Instruction for the patient You are 32 years old, divorced and have one child; you have just started a new relationship You underwent surgical resection of the left
Diabetes in pregnancy
Diabetes in pregnancy Bipin Sethi Department of Endocrinology Care Hospitals Hyderabad, India Declared no potential conflict of interest Diabetes in pregnancy Bipin Kumar Sethi Department of Endocrinology,
C V NAME: MEDHAT YEHIA MOHAMED ANWAR MARIATAL SATATUS : MARRIED WITH 3 CHILDREN
C V NAME: MEDHAT YEHIA MOHAMED ANWAR DATE OF BIRTH : 24/8/1951 PLACE OF BIRTH : CAIRO, EGYPT MARIATAL SATATUS : MARRIED WITH 3 CHILDREN ADDRESS : 264 ABDEL SALAM AREF FACING SARAYA TRAM STATION, FLAT 403
Dr. Nancy Van Eyk Associate Professor, Dalhousie University Chief of Gynaecology, IWK Health Centre
Dr. Nancy Van Eyk Associate Professor, Dalhousie University Chief of Gynaecology, IWK Health Centre AUB Outline Terminology Classification/Etiology Assessment Treatment Referral to Gynaecology U c pt 4
Medical Eligibility for Contraception Use
Medical Eligibility for Contraception Use DIVISION OF REPRODUCTIVE HEALTH CENTERS FOR DISEASE CONTROL AND PREVENTION 2016 US Medical Eligibility Criteria for Contraceptive Use (US MEC) Purpose To assist
Teaching Schedule of P.G. Student.
Teaching Schedule of P.G. Student. Vaginal Hysterectomy Modified Radical Hysterectomy Laparoscopic Hysterectomy Epithelial Ovarian Germ Cell Tumor of Ovary Cervix Cervix Chorio Endometrial Vulvar Vulvar
CLEAR COVERAGE HYSTERECTOMY CHECKLISTS
CLEAR COVERAGE HYSTERECTOMY CHECKLISTS Click on the link below to access the checklist sheet. Abnormal Uterine Bleeding Adenomyosis Chronic Abdominal or Pelvic Pain Endometriosis Fibroids General Guidelines
Normal and Abnormal Development of the Genital Tract. Dr.Raghad Abdul-Halim
Normal and Abnormal Development of the Genital Tract Dr.Raghad Abdul-Halim objectives: Revision of embryology. Clinical presentation, investigations and clinical significance of most common developmental
All referrals for out-patient appointments can also be discussed with the Obstetrics and Gynaecology registrar as necessary. Presence of ascites
Gynaecology Referral Pathway for GPs to Aid Triage for Gynaecology Services in the Rotunda For acute gynaecology (suspected torsion, acute PID, etc..) or acute early pregnancy referrals please consider
Log Title: OBRES Gynecologic Case Log
Log Title: OBRES Gynecologic Case Log Hospital/Institution: (Lookup) Attending Physician (Lookup) Is Patient Pregnant? ( Y or N) MEDRECNO: (text) Date (encounter) (Date) Diagnosis DX GYN Acute Pelvic Pain
Maternal and perinatal outcome in antenatal women with hypothyroidism
Original Research Article Maternal and perinatal outcome in antenatal women with hypothyroidism Polumuru Usha Devi 1, Gundu Vanaja 1* 1 Assistant Professor of Obstetrics and Gynecology, Andhra Medical
Gynaecological Malignancies
Gynaecological Malignancies Dr Rodney Itaki Lecturer Anatomical Pathology Discipline University of Papua New Guinea Division of Pathology School of Medicine & Health Sciences Overview Genital tract tumors
The Centre for Reproductive Medicine HYSTERECTOMY
The Centre for Reproductive Medicine PO Box 20559 Nimbin NSW 2480 Australia Maxwell Brinsmead MB BS PhD MRCOG FRANZCOG Phone + 61 409 870 346 Retired Obstetrician & Gynaecologist E-mail max@brinsmead.net.au
Pathway Gynaecology Cancer & Diagnostic Protocol for Inter Trust transfer
NICaN Pathway Gynaecology Cancer & Diagnostic Protocol for Inter Trust transfer Timed schedules to enable the proactive management of the patient from point of receipt of referral to first definitive treatment
2/13/2018. Update on Gestational Diabetes. Disclosure. Objectives. I have no financial conflicts of interest.
Update on Gestational Diabetes Lorie M. Harper, MD, MSCI Department of Obstetrics & Gynecology Division of Maternal-Fetal Medicine 2/18/2018 Disclosure I have no financial conflicts of interest. Objectives
Levosert levonorgestrel 20mcg/24hour intrauterine device
Levosert levonorgestrel 20mcg/24hour intrauterine device Verdict: Formulary inclusion: Formulary category: Restrictions: Reason for inclusion: Link to formulary: Link to medicine review summary: Levosert
Management of Pregestational and Gestational Diabetes Mellitus
Background and Prevalence Management of Pregestational and Gestational Diabetes Mellitus Pregestational Diabetes - 8 million women in the US are affected, complicating 1% of all pregnancies. Type II is
Abnormal Uterine Bleeding. Richard Dover Specialist gynaecologist
Abnormal Uterine Bleeding Richard Dover Specialist gynaecologist A pragmatic guide. Wide topic range What s not coming up Precocious puberty Menorrhagia well maybe just a little Topics Adolescents IMB
Ovaries: In Sickness and Health. Mr N Pisal Consultant Gynaecologist The Portland Hospital
Ovaries: In Sickness and Health Mr N Pisal Consultant Gynaecologist The Portland Hospital Topics for discussion How to assess ovarian function? AMH PCOS Ovarian pain Ovarian cysts Ovarian screening Menopause
Application for inclusion of levonorgestrel - releasing IUD for contraception in the WHO Model List of Essential Medicines
Application for inclusion of levonorgestrel - releasing IUD for contraception in the WHO Model List of Essential Medicines 1. Summary statement of the proposal for inclusion LNG-IUS is an effective contraceptive;
Menstrual Disorders & Ambulatory Gynaecology
Menstrual Disorders & Ambulatory Gynaecology Mr. Nagui Lewis Aziz M B, CH B, FRCOG Consultant Gynaecologist The Royal Oldham Hospital 01/09/2018 Heavy menstrual bleeding (HMB ) is a common problem responsible
Women s Health: Take Home Messages
Women s Health: Take Home Messages Caren Solomon, MD Associate Physician, BWH Associate Professor of Medicine, HMS Deputy Editor, NEJM No disclosures Contraception Contraceptive Effectiveness Rates of
Wendy Shen, MD, PhD Refresher Course for the Family Physician April 5, 2018 Coralville, Iowa
Wendy Shen, MD, PhD Refresher Course for the Family Physician April 5, 2018 Coralville, Iowa Objectives Distinguish the different types of IUDs Understand the mechanism of action and selection of candidates
CHAPTER 13 Gynaecological Procedures
CHAPTER 13 Propunere noua clasificare proceduri folosind codificarea ICD-10-AM versiunea 3, 30 martie 2004 Gynaecological Procedures BLOCK 1240 Application, insertion or removal procedures on ovary 35518-00
PERSONAL CHARACTERISTICS AND REPRODUCTIVE HISTORY...3 Pregnancy...3 Age...3 Parity...3 Breastfeeding...3 Postpartum...3 Post-abortion...
Table of contents Summary tables PERSONAL CHARACTERISTICS AND REPRODUCTIVE HISTORY...3 Pregnancy...3 Age...3 Parity...3 Breastfeeding...3 Postpartum...3 Post-abortion...3 Past ectopic pregnancy...3 History
JMSCR Vol 05 Issue 07 Page July 2017
www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i7.181 Evaluating Foleys Balloon Catheter Tamponade
5/5/2010 FINANCIAL DISCLOSURE. Abnormal Uterine Bleeding. Is This A Problem? About me % of visits to gynecologist
Abnormal Uterine FINANCIAL DISCLOSURE I HAVE NO FINANCIAL INTEREST IN ANY OF THE PRODUCTS MENTIONED IN MY PRESENTATION Bryan K. Rone, M.D. University of Kentucky Obstetrics and Gynecology May 5, 2010 About
CURRICULUM VITAE. Fida F Asali. M.B, B.S, MSc, MRCOG, DFSRH
CURRICULUM VITAE Fida F Asali M.B, B.S, MSc, MRCOG, DFSRH Assistant Professor in Obstetrics and Gynaecology Consultant in Obstetrics and Gynaecology Faculty of Medicine The Hashemite University 1 Personal
Welcome to Mirena. The Mirena Handbook: A Personal Guide to Your New Mirena. mirena.com. Mirena is the #1 prescribed IUD * in the U.S.
Mirena is the #1 prescribed IUD * in the U.S. Welcome to Mirena The Mirena Handbook: A Personal Guide to Your New Mirena *Intrauterine Device Supported by 2015-2016 SHS data INDICATIONS FOR MIRENA Mirena
Gayatrri Anipindi *, Vani I. Original Research Article. Abstract
Original Research Article Role of levonorgestrel releasing intrauterine device in management of heavy menstrual bleeding: A safe and effective option for all PALM COEIN variants Gayatrri Anipindi *, Vani
Example Clinical Guideline for Immediate Postpartum LARC Insertion
Example Clinical Guideline for Immediate Postpartum LARC Insertion RATIONALE Delay in contraceptive provision until the six week postpartum appointment can leave some women at risk for rapid repeat pregnancy.
Lindsey Tingen, MD Department of Obstetrics and Gynecology, Greenville Health System Greenville, SC
Postpartum IUD Insertion: Continued Usage at Six Months Based on Expulsion and Removal Rates at Greenville Memorial Hospital in the First Year After Adoption of the Practice Lindsey Tingen, MD Department
Topics. Periods Menopause & HRT Contraception Vulva problems
Girls stuff Topics Periods Menopause & HRT Contraception Vulva problems Menorrhagia Excessive menstrual loss occurring with regular or irregular cycles Ovulatory Anovulatory Usual blood loss 30-40ml per
bleeding Studies naar de diagnostiek van endom triumcarcinoom bij vrouwen met postm nopauzaal bloedverlies. Studies on the
Studies on the diagnosis of endometria cancer in women with postmenopausal bleeding. Studies naar de diagnostiek va endometriumcarcinoom bij vrouwen m postmenopauzaal bloedverlies. Studies on the diagnosis
The Impact of Insulin Resistance on Long-Term Health in PCOS
Saturday, April 16 th, 2016 PCOS Challenge & Thomas Jefferson University PCOS Awareness Symposium Philadelphia The Impact of Insulin Resistance on Long-Term Health in PCOS Katherine Sherif, MD Professor
FDA-Approved Patient Labeling Patient Information Mirena (mur-ā-nah) (levonorgestrel-releasing intrauterine system)
FDA-Approved Patient Labeling Patient Information Mirena (mur-ā-nah) (levonorgestrel-releasing intrauterine system) Mirena does not protect against HIV infection (AIDS) and other sexually transmitted infections
Training matrix. Annual expectation of educational progression ST1 to ST7 in O&G for
Training matrix Annual expectation of educational progression ST1 to ST7 in O&G for 2016-17 1 These standards represent the minimum required. Trainees are encouraged to exceed these requirements. Please
Supplemental Digital Content: Definitions Based on the International Classification of Diseases, Ninth Revision, Clinical Modification
Supplemental Digital Content: Definitions Based on the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) Diagnose and Procedures Codes 1. ICD-9-CM definition of
Product Information. Confidence that lasts
Confidence that lasts What is Mirena? Inhibition of sperm motility and function inside the uterus and the fallopian tubes, preventing fertilization (Videla-Rivero et al. 1987). Section of system Levonorgestrel
International Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Evaluation of Thyroid Profile in Patients with Abnormal Uterine Bleeding Rema. V. Nair 1*,
ACCESS LARC INCREASING ACCESS TO IMMEDIATE POSTPARTUM LONG-ACTING REVERSIBLE CONTRACEPTION
ACCESS LARC INCREASING ACCESS TO IMMEDIATE POSTPARTUM LONG-ACTING REVERSIBLE CONTRACEPTION Chapter Four: Policies and Procedures Overview This procedure outline is a pre-cursor to detailed procedures related
the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD your guide to
your guide to Helping you choose the method of contraception that s best for you IUD IUD the e IUD IU IUD the IUD 2 3 The intrauterine device (IUD) An IUD is a small plastic and copper device that s put
Post - caesarean section pyrexia and its relation of rupture of membranes and prophylactic antibiotics
MOJ Women s Health Research Article Open Access Post - caesarean section pyrexia and its relation of rupture of membranes and prophylactic antibiotics Abstract Objectives: To determine the incidence of
2018 Standard of Medical Care Diabetes and Pregnancy
2018 Standard of Medical Care Diabetes and Pregnancy 2018 Standard of Medical Care Diabetes and Pregnancy Marjorie Cypress does not have any relevant financial relationships with any commercial interests
Diabetes in Pregnancy
Disclosure Diabetes in Pregnancy I have no conflicts of interest to disclose Jennifer Krupp, MD Maternal Fetal Medicine St. Marys Hospital/SSM Health Madison, WI Objectives Classification of Diabetes Classifications
Supplemental figure 1. Adjusted odds ratios for gestational diabetes, pre-eclampsia, premature birth and miscarriage for women with and without PCOS.
Supplemental figure 1 Adjusted odds ratios for gestational diabetes, pre-eclampsia, premature birth and miscarriage for women with and without PCOS. * Denominator is all pregnancies, adjusted for age,
The Pediatric Gynecology Fellowship at the Hospital for Sick Children at the University of Toronto, is a one year program.
The Hospital for Sick Children Pediatric Gynecology Fellowship Objectives Introduction The Pediatric Gynecology Fellowship at the Hospital for Sick Children at the University of Toronto, is a one year
Role of diagnostic hysteroscopy in evaluation of abnormal uterine bleeding and its histopathological correlation
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Chaudhari KR et al. Int J Reprod Contracept Obstet Gynecol. 2014 Sep;3(3):666-670 www.ijrcog.org pissn 2320-1770 eissn 2320-1789
U.S. Medical Eligibility Criteria for Contraceptive Use, 2010
U.S. Medical Eligibility Criteria for Contraceptive Use, 2010 Division of Reproductive Health Centers for Disease Control and Prevention August 1, 2013 National Center for Chronic Disease Prevention and
Downloaded from:
Calvert, C; Ronsmans, C (2013) The contribution of hiv to pregnancy mortality: a systematic review and meta-analysis. AIDS (London, England), 27 (10). pp. 1631-9. ISSN 0269-9370 DOI: https://doi.org/10.1097/qad.0b013e32835fd940
Chapter 100 Gynecologic Disorders
Chapter 100 Gynecologic Disorders Episode Overview: 1. Describe the presentation and RF for Adnexal torsion 2. List the imaging findings of adnexal torsion (US vs CT) 3. What is the management of adnexal
INFERTILITY CAUSES. Basic evaluation of the female
INFERTILITY Infertility is the inability to conceive after 12 months of unprotected intercourse. There are multiple causes of infertility and a systematic way to evaluate the condition. Let s look at some
CASES: DIABETES AND PREGNANCY
CASE 1: Visit 1: Ms. Sunny Disposition is a 32 yo G2P1001 who is approximately 15 weeks here for her first prenatal visit. She has already had an US but records not yet received. Pmhx: Unremarkable, no
Dedicated postpartum IUD inserter. Dr. Anne Burke, Johns Hopkins Medicine Dr. Leo Han, OHSU Healthcare July 13, 2016
Dedicated postpartum IUD inserter Dr. Anne Burke, Johns Hopkins Medicine Dr. Leo Han, OHSU Healthcare July 13, 2016 Unmet need for FP in postpartum period Across 27 countries, 65% of postpartum women had
1. Ortiz, M. E et al. Mechanisms of action of intrauterine devices. Obstet & Gynl Survey 1996; 51(12), 42S-51S.
1 2 1. Ortiz, M. E et al. Mechanisms of action of intrauterine devices. Obstet & Gynl Survey 1996; 51(12), 42S-51S. The contraceptive action of all IUDs is mainly in the uterine cavity. The major effect
Objectives. Outline. Section 1: Interaction between HIV and pregnancy. Effects of HIV on Pregnancy. Section 2: Mother-to-Child-Transmission (MTCT)
Objectives Prevention of Mother-to-Child Transmission (PMTCT) Teen Club Community Partners Training Programme By the end of the session participants will be able to: 1. Identify factors affecting the transmission
What s New in Adolescent Contraception?
What s New in Adolescent Contraception? Abby Furukawa, MD Legacy Medical Group Portland Obstetrics and Gynecology April 29, 2017 Objectives Provide an update on contraception options for the adolescent
Summary of the risk management plan (RMP) for Duavive (conjugated oestrogens / bazedoxifene)
EMA/679870/2014 Summary of the risk management plan (RMP) for Duavive (conjugated oestrogens / bazedoxifene) This is a summary of the risk management plan (RMP) for Duavive, which details the measures
Urological Complications in Gynecological Surgery and Radiotherapy
Urological Complications in Gynecological Surgery and Radiotherapy Contributions to Gynecology and Obstetrics Vol. 11 Series Editor P. J. Keller, Zürich ]11Wξ]1 Contributions to S. Karger Basel München
Heavy Menstrual Bleeding. Mr Nick Nicholas MD FRCOG Grad Dip Law. Consultant Gynaecologist
Heavy Menstrual Bleeding Mr Nick Nicholas MD FRCOG Grad Dip Law. Consultant Gynaecologist Why is HMB so important? 1:20 women aged 30-49 consult their GP with HMB Once referred to gynaecologist, surgical
International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:
Review Article ISSN: 2319 9563 International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage: www.ijrpns.com A REVIEW ON INTRAUTERINE DEVICES Boddu Venkata Komali* 1, M. Kalyani
Group D & E Theme: Pituitary & Thyroid gland diseases Week/Time Monday Tuesday Wednesday Thursday Friday. Lecture: Thyroiditis. Venue: Lecture hall 2
Group D & E Week (6 th July 208) Theme: Pituitary & Thyroid gland diseases 09:3-0:30 Extra Sessions Clinical Rotations Pituitary gland Lecture: Hormones of anterior & posterior pituitary gland Lecture:
POSTGRADUATE COURSE IN REPRODUCTIVE HEALTH POSTPARTUM INFECTION
POSTGRADUATE COURSE IN REPRODUCTIVE HEALTH POSTPARTUM INFECTION INTRODUCTION Postpartum infection continue to be one of the major recognisable post- natal complications in developing countries Due to lack
Labor & Delivery Management for Women Living with HIV. Pooja Mittal, DO Lisa Rahangdale, MD
Labor & Delivery Management for Women Living with HIV Pooja Mittal, DO Lisa Rahangdale, MD Statistics for Perinatally Acquired HIV Timing of Perinatal HIV Transmission Most transmission occurs close to
North American Menopause Society (NAMS)
North American Menopause Society (NAMS) 2012 Hormone Therapy Position Statement Cynthia B. Evans, MD Assistant Professor-Clinical Department of Obstetrics and Gynecology The Ohio State University College
Gynecological Cancers
Gynecological Cancers Outline Ovarian Cancer Uterine (Endometrial) Cancer Cervical Cancer Vulvar Cancer Vaginal Cancer Overian Cancer Ovarian cancer is cancer that forms in the tissue of the ovary and
Pap Smears Pelvic Examinations Well Woman Examinations. When should you have them performed???
Pap Smears Pelvic Examinations Well Woman Examinations. When should you have them performed??? Arlene Evans-DeBeverly, PA-C Copyright 2012 There are always ongoing changes in gynecology, including the
Sexual differentiation:
Abnormal Development of Female Genitalia Dr. Maryam Fetal development of gonads, external genitalia, Mullerian ducts and Wolffian ducts can be disrupted at a variety of points, leading to a wide range
DIP.G.O. EXAMINATION 2007
DIP.G.O. EXAMINATION 2007 GYNAECOLOGY Batch A/07 Time : 2 hrs. Question 1. a. Define Dysfunctional Uterine Bleeding 10 b. What are the various terms used to describe menstrual disorder? 10 Question 2.
Primary Care Gynaecology Guidelines: HEAVY REGULAR MENSTRUAL BLEEDING
Primary Care Guidelines: HEAVY REGULAR MENSTRUAL BLEEDING
Comparative study of interval versus postpartum Cu-T insertion in a central referral hospital of North East India
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Lucksom PG et al. Int J Reprod Contracept Obstet Gynecol. 2015 Feb;4(1):47-51 www.ijrcog.org pissn 2320-1770 eissn 2320-1789
[KT 556] AUGUST 2008 Sub. Code : 4086
![[KT 556] AUGUST 2008 Sub. Code : 4086](/thumbs/93/114130125.jpg "[KT 556] AUGUST 2008 Sub. Code : 4086")
[KT 556] AUGUST 2008 Sub. Code : 4086 FINAL M.B.B.S. DEGREE EXAMINATION Revised (Non-Semester) Regulations Time : Three hours Maximum: 100 Marks I. Essay Questions : (2 x 15 = 30) 1. What are the causes
NUTRITIONAL INTERVENTIONS DURING PREGNANCY FOR THE PREVENTION OR TREATMENT OF MATERNAL MORBIDITY, MORTALITY OR PRETERM DELIVERY
NUTRITIONAL INTERVENTIONS DURING PREGNANCY FOR THE PREVENTION OR TREATMENT OF MATERNAL MORBIDITY, MORTALITY OR PRETERM DELIVERY OVERVIEW OF RANDOMISED CONTROLLED TRIALS José Villar,, Mario Merialdi,, A